NCT00869050 2016-07-25Capecitabine and Temozolomide for Neuroendocrine CancersColumbia UniversityPhase 2 Completed41 enrolled 9 charts
NCT00416767 2016-05-30Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryFederation Francophone de Cancerologie DigestivePhase 2 Completed20 enrolled
NCT00027638 2013-06-18Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Completed